Related Experiment Video
Updated: Jul 22, 2026
07:39
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
New insights into childhood ependymomas
1Division of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA. rpacker@cnmc.org
Current Neurology and Neuroscience Reports
|March 4, 2005
Summary
Childhood ependymomas are challenging pediatric brain tumors. Current treatments have variable success, and optimal therapeutic strategies are still under investigation.
Area of Science:
- Pediatric neuro-oncology
- Central nervous system tumors
Background:
- Childhood ependymomas represent 10-15% of pediatric brain tumors.
- These tumors present significant treatment challenges.
- Relapse-free survival rates are inconsistent across studies.
Purpose of the Study:
- To review the current state of childhood ependymoma treatment.
- To highlight the variability in therapeutic outcomes.
- To underscore the need for refined treatment protocols.
Main Methods:
- Literature review of contemporary series.
- Analysis of relapse-free survival data.
- Discussion of current therapeutic approaches.
Main Results:
- Significant variation in relapse-free survival rates observed.
- Lack of consensus on optimal treatment strategies.
- Ependymomas remain a problematic tumor group.
Conclusions:
- Childhood ependymomas require further research for improved outcomes.
- Standardized therapeutic approaches are needed.
- Advances in treatment are critical for this patient population.
